Posted on March 2, 2012 by Albin Paul
The New Medicine Service (NMS) offered by Engalnd’s NHS community pharmacies came into effect since 1st October 2011. NMS is a patient adherene service and focuses on patients with long term conditions that have been prescribed new medicines. It is hoped that NMS will lead to the following outcomes: improve medicines adherence increase patient engagement with [...]
Filed under: personalized medicine, patient adherence | Tagged: patient adherence, medication adherence, predictive analytics, new medicine service, prescription compliance, healthcare analytics | Leave a Comment »
Posted on February 9, 2011 by Albin Paul
AstraZeneca Pharmaceuticals LP (NYSE: AZN) and HealthCore, Inc., the health outcomes research subsidiary of WellPoint, Inc. (NYSE: WLP), announced a collaborative agreement to conduct real-world studies designed to determine how to most effectively and economically treat disease Unlike controlled clinical trials, real-world evidence studies use observational data such as electronic medical records, claims information and [...]
Filed under: clinical research, Clinical Trial, personalized medicine, Pharmacogenomics | Leave a Comment »
Posted on November 17, 2010 by Albin Paul
According to a new report from the Tufts Center for the Study of Drug Development at Tufts University 12 to 50 percent of the drugs companies are developing, depending on the company, involved a personalized medicine approach. The Tufts report is based on a survey of 25 companies, large and small, to which 16 companies [...]
Filed under: clinical research, Clinical Trial, drug development, drug discoverry, personalized medicine, Pharmacogenomics, Theranostics | Tagged: Drug Development, drug discovery, personalized medicine, theranostics | Leave a Comment »
Posted on November 17, 2010 by Albin Paul
George Whitesides, a Harvard chemistry professor has designed technology in which patients’ blood is dropped on a piece of paper, and water-repellent ink resembling that of a comic book creates diagnostic colors on the other side, CNN reports. The technology may be incorporated into mobile phones, according to CNN. Whitesides’ prototype allows for testing of [...]
Filed under: personalized medicine, Theranostics | Tagged: clinical research, Clinical Trial, Drug Development, drug discovery | Leave a Comment »
Posted on November 17, 2010 by Albin Paul
UK’s Medical Research Council grants a Clinical Research consortium $6.4 million to develop chips & software to use mobile phones/PCs as testing devices for sexually transmitted disease (STD) If successful individuals will drop their blood, urine or saliva on a mobile chip, which they then insert into a mobile phone or PC. Software on the [...]
Filed under: clinical research, clinical software, Clinical Trial, personalized medicine, Theranostics | Tagged: clinical research, Clinical Trial, Drug Development | 1 Comment »
Posted on September 30, 2010 by Albin Paul
The Institute is focused on research that will accelerate IT innovation to advance personalized medicine and the delivery of safe and effective treatments and health care services to patients around the globe. OHSI will work in tandem with academic research centers, focusing on a targeted set of research areas fundamental to the R&D and [...]
Filed under: Drug Safety, genetic medicine, Online Data sharing, open access database, open source, oracle, Oracle Health Sciences Global Business Unit, Patient Safety, personalized medicine, Pharmacogenomics, pharmacovigilance | Tagged: Drug Safety, health sciences global business unit, HSGBU, OHSI, Open Source Drug Development Network, oracle, Oracle Health Science Global Business Unit, Oracle Health Sciences Institute, personalized medicine, Pharmacogenomics, pharmacovigilance, Sun Labs | 1 Comment »
Posted on August 10, 2010 by Albin Paul
Single patient Clinical Trial are not new idea, FDA did not focus since such trial canot prove the efficacy and safety of medicine over a large pool of patient with sufficient data. But I was forced to re-think after reading the article http://www.technologyreview.in/biomedicine/12537/ why cant we use the the concept mentioned in to overcome the [...]
Filed under: clinical research, Clinical Trial, Patient Safety, personalized medicine, pharmacovigilance | Tagged: health sciences global business unit, Oracle health sciences global business unit | 1 Comment »
Posted on April 22, 2009 by Albin Paul
BIO-IT WORLD COVERAGE ON INTEGRATING CLINICAL AND GENOMICS DATA AND PLATFORMS FOR PERSONALIZED MEDICINE The March-April 2009 issue of Bio-IT World features Dana-Farber Cancer Institute cover story on integrating clinical and genomics data including details on the organization’s work with Oracle and InforSense, as well as a byline article on platforms for personalized medicine by [...]
Filed under: clinical informatics, personalized medicine | Tagged: clinical data management, clinical research | 1 Comment »
Posted on June 24, 2008 by Albin Paul
State of New York has issues warning against Personal genomics companies , after they have received many complaints. Now the State of California Department of Helath (CDPH) is trying to keep consumer genetic testing companies from offering their services to the state’s residents and last week sent letters to 13 firms saying they are violating [...]
Filed under: clinical genomics, genetic testing, personalized medicine | Tagged: personal genomics | 2 Comments »
Posted on June 10, 2008 by Albin Paul
I have written quiet often about this subject and companies that promises solution for personalized medicine. especially the use of genomics information in organ transplant patients and cancer treatment. XDx and Genomic Health are two such companies . XDX has applied microarray, to monitor the immune system, with the help of Gene expression to address [...]
Filed under: clinical microarray, gene expression, microarray, personalized medicine | 4 Comments »
Posted on January 3, 2008 by Albin Paul
A service launched by quintiles claims to be one of the first to provide post launch drug safety information about drugs directly to any one who is using them. iGuard is a web-based services that will help you take medication safety without the help of healthcare professionals. You can register on the site for free [...]
Filed under: clinical informatics, personalized medicine | 1 Comment »
Posted on December 18, 2007 by Albin Paul
CombiMatrix has completed the clinical validation of the BAC array CGH based clinical microarray tests. ATScan is designed to detect known genomic copy-number variations associated with Autism Spectrum Disorder and this test is now available to physicians and consumers.
Filed under: Clinical microarrays, microarray blog, microarray for clinical diagnostics, Next Generation of DNA and RNA Microarrays, personalized medicine, Pharmacogenomics | 3 Comments »
Posted on November 6, 2007 by Albin Paul
Medgadget reports about the IP Development Company Gentag and Frank Sammeroff working on a new smart, wireless ID skin patch technology that aims to reduce medical errors in hospitals worldwide, This patented, non-invasive solution combines disposable skin patches with RFID tags and cellphones, enabling doctors and nurses to use their handsets or wireless PDAs [...]
Filed under: personalized medicine, science blog | Leave a Comment »
Posted on October 23, 2007 by Albin Paul
Move over the TeleMedicine and the usual chutzpah, Yesd Web2.0 is a bubble thats going to burst, but in healthcare field strangled by Insurannce companies, web2.0 is giving a whiff of relief to some people atleast , How! WebMD ,MayoClinic ,eMedTV are few site that offers to help you through videos, blogs and other channels Officials at the Department of Health [...]
Filed under: personalized medicine, science on TV, six degrees of separation, web2.0 | Leave a Comment »
Posted on October 15, 2007 by Albin Paul
It hardly a week I have wrote about acquisition and mergers , it seems the rain is noit going to stop any time soon, the latest one , to give away the home plate is Genelogic agreeing to sell its genomics division to India HQ Ocimum Biosolutions subject to the authorization of the transaction at [...]
Filed under: bioinformatics blog, bioinformatics company, bioinformatics industry, Genomics, genomics company, microarray blog, microarray business, outsourcing, personalized medicine, Pharmacogenomics, toxicogenomics | Leave a Comment »
Posted on October 11, 2007 by Albin Paul
Its the time -Personalized Genomics Advances in genetic information and laboratory technologies mean new ways to diagnose disease and determine patient risk. The wealth of genetic information makes it harder to provide meaningful information. During Oracle OpenWorld 2007 Oracle is presenting how laboratory information systems principles and Oracle customer relationship management and enterprise resource planning [...]
Filed under: bioinformatics, clinical genomics, microarray blog, oracle, personalized medicine, Pharmacogenomics | Leave a Comment »
Posted on August 20, 2007 by Albin Paul
IT been a long time since my last post, So I thought of catching up with other blogger before going to do anything myslef. So here is what got my attention from Alla Katsnelson blog on the scientist magazine that USFDA approved updated labeling for the widely used blood-thinning drug, Coumadin, to explain that people’s [...]
Filed under: gene expression, genetics, Genomics, microarray blog, personalized medicine, Pharmacogenomics, science blog | 1 Comment »
Posted on July 21, 2007 by Albin Paul
Personalized Medicine in 60 Seconds Bioinformatics was a BOOM its was predicted to be next big thing, yet the industry which had hundereds of fragmented mom and pop kind small companies are now under mergers and acquisitions, Does everyone got their money back. Bioinformatics is yet to become the big Billion billion Dollar, and on [...]
Filed under: bioinformatics blog, microarray blog, personalized medicine, science blog | 3 Comments »
Posted on July 21, 2007 by Albin Paul
Affymetrix expands into personalized medicine! Why because The next big thing in health care? is You the individual personalized medicine is the place step every one wants to be. Roche recently went after Nimblegen for a small foothold in this developing ssicne field, Now its the turn of Affymetrix the leader in microarray DNA chips. [...]
Filed under: Affymetrix, bioinformatics blog, DNA medicine, gene expression, genetics, Genomics, microarray blog, microarray for clinical diagnostics, personalized medicine, Pharmacogenomics, Theranostics | 2 Comments »
Posted on June 23, 2007 by Albin Paul
I have been busy lately but found some time to go through an interesting story and a good article published in scientist magazine Father-in-law of now-infamous extensively drug-resistant TB patient studies tuberculosis at the CDC, and is now under review by the agency Genotyping with PCR -How to choose the right approach I am working on an [...]
Filed under: bioinformatics blog, clinical diagnostics, clinical microarray, diagnostic microarray, DNA diagnostics, DNA medicine, microarray blog, microarray business, personalized medicine, Theranostics | Leave a Comment »